Rentschler Biopharma SE and Leukocare AG report successful first year of unique strategic alliance
Rentschler Biopharma SE and Leukocare AG today reported on the successful first year of their unique strategic alliance.
Rentschler Biopharma SE appoints Federico Pollano as senior vice-president, business development
Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today announced that Federico Pollano (55) has joined the Company...
Rentschler Biopharma SE appoints international biopharma expert Dr Ralf Otto as chief operating officer
Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto (46) as chief operating officer...
Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE
Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that the Company has successfully...
Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities
Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent...
Rentschler and Leukocare announce strategic alliance and equity investment
Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialised technology partner and...
Rentschler announces 4th Laupheim Biotech Days taking place in June 2016
The Laupheim Biotech Days – formally known as Laupheimer Zelltage – provide a unique platform for the international exchange of knowledge, ideas and expertise. Held every two years,...